Barron’s Top Weekend Stock Picks: Tesla, Bed Bath & Beyond, Six Flags And Signs Bitcoin Whales Are Buying The Dip
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.
Bulls And Bears Of The Week: Apple, AMC, Meta, And How Elon Musk Is Reacting To Tesla Stock Plunge
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca
GSK plc (NYSE: GSK) chief commercial officer Luke Miels says the company is looking at M&A targets that are under-appreciated worth $1 billion-$2.5 billion and avoid getting into a 'bidding war.'
Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates
Novavax Inc (NASDAQ:NVAX) has initiated a Phase 2 trial for its COVID-19-Influenza Combination (CIC) and influenza stand-alone vaccine candidates. The…
New Oral COVID-19 Antiviral Might Be Better Than Pfizer’s Paxlovid With Faster Recovery, Fewer Side Effects, Data Shows
A study in China shows that a remdesivir analog, dubbed VV116, is as effective as Pfizer Inc's (NYSE: PFE) oral COVID-19 pill.
How One Of The Most ‘Woke’ CEOs In The U.S. Went From Unloading Trucks To Earning $25 Million
Carl “Doug” McMillon has spent most of his life working for Walmart Inc (NYSE: WMT).
Novartis Settles Antitrust Cases Related To Generic Entry For Hypertension Drug
Novartis AG (NYSE: NVS) will pay $245 million to end antitrust litigation accusing the company of trying to delay the U.S. launch of generic versions of its Exforge, which treats hypertension to lower blood pressure and reduce the risk of strokes.
Exxon Mobil Sues European Union In Efforts To Scrap New Windfall Tax On Oil Firms
Exxon Mobil Corp (NYSE: XOM) has reportedly sued the European Union to remove the bloc's new windfall tax on oil groups.